2019
CCM3 and cerebral cavernous malformation disease
Wang K, Zhou HJ, Min W. CCM3 and cerebral cavernous malformation disease. Stroke And Vascular Neurology 2019, 4: svn-2018-000195. PMID: 31338212, PMCID: PMC6613868, DOI: 10.1136/svn-2018-000195.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsApoptosis Regulatory ProteinsCapillary PermeabilityCell MovementCell ProliferationCerebral ArteriesEndothelial CellsGenetic Predisposition to DiseaseHemangioma, Cavernous, Central Nervous SystemHumansMembrane ProteinsMutationNeovascularization, PathologicPhenotypeProto-Oncogene ProteinsSignal TransductionConceptsCerebral cavernous malformationsSmall blood vesselsTreatment of CCMsCerebral cavernous malformation diseaseBlood vesselsRisk of strokeUnique biological functionsPotential therapeutic strategyFocal neurological defectsCCM proteinsEndothelial cell junctionsCCM3/Vascular lesionsBiological functionsDifferent genesCCM genesCavernous malformationsSevere formTherapeutic strategiesCell junctionsNeurological defectsSimilar functionsMalformation diseaseCCM diseaseDisease
2017
Smooth muscle cell differentiation: Mechanisms and models for vascular diseases
Deng Y, Lin C, Zhou H, Min W. Smooth muscle cell differentiation: Mechanisms and models for vascular diseases. Frontiers In Biology 2017, 12: 392-405. DOI: 10.1007/s11515-017-1473-z.Peer-Reviewed Original ResearchVSMC differentiationVascular diseaseVSMC behaviorEnvironmental cuesVSMC phenotypeMolecular mechanismsPhenotypic switchingPhenotype modulationMature cellsNew therapeutic targetsSynthetic stateProgenitor cellsSmooth muscle cellsMuscle cellsCritical roleVascular-related diseasesTherapeutic targetDifferentiationCardiovascular diseaseCardiovascular conditionsCellsContractile stateDiseaseComprehensive understandingPhenotype